Works matching IS 00099236 AND DT 2009 AND VI 86 AND IP 5
Results: 26
Population Analyses of Atorvastatin Clearance in Patients Living in the Community and in Nursing Homes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 497, doi. 10.1038/clpt.2009.100
- By:
- Publication type:
- Article
Hydrochlorothiazide and Atenolol Combination Antihypertensive Therapy: Effects of Drug Initiation Order.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 533, doi. 10.1038/clpt.2009.101
- By:
- Publication type:
- Article
Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 507, doi. 10.1038/clpt.2009.103
- By:
- Publication type:
- Article
Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 540, doi. 10.1038/clpt.2009.104
- By:
- Publication type:
- Article
Effects of Selective Serotonin Reuptake Inhibitor Therapy on Endothelial Function and Inflammatory Markers in Patients With Coronary Heart Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 527, doi. 10.1038/clpt.2009.121
- By:
- Publication type:
- Article
Use of the MDRD Study Equation to Estimate Kidney Function for Drug Dosing.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Drug Dosing in Patients With Impaired Renal Function.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 483, doi. 10.1038/clpt.2009.135
- By:
- Publication type:
- Article
Public Health Consequences of Chronic Kidney Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 566, doi. 10.1038/clpt.2009.137
- By:
- Publication type:
- Article
Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 519, doi. 10.1038/clpt.2009.141
- By:
- Publication type:
- Article
Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 511, doi. 10.1038/clpt.2009.145
- By:
- Publication type:
- Article
How Will GINA Influence Participation in Pharmacogenomics Research and Clinical Testing?
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 472, doi. 10.1038/clpt.2009.146
- By:
- Publication type:
- Article
Pharmacokinetic Studies in Hemodialysis Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 548, doi. 10.1038/clpt.2009.147
- By:
- Publication type:
- Article
Continuing the Use of the Cockcroft–Gault Equation for Drug Dosing in Patients With Impaired Renal Function.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Challenges in Developing Evidence-Based Drug Dosing Guidelines for Adults and Children Receiving Renal Replacement Therapy.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
The Impact of Continuous Renal Replacement Therapy on Drug Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 562, doi. 10.1038/clpt.2009.152
- By:
- Publication type:
- Article
The Influence of Chronic Renal Failure on Drug Metabolism and Transport.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 553, doi. 10.1038/clpt.2009.163
- By:
- Publication type:
- Article
Drug Development Perspective on Pharmacokinetic Studies of New Drugs in Patients With Renal Impairment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 557, doi. 10.1038/clpt.2009.182
- By:
- Publication type:
- Article
Novel Biomarkers of Acute Kidney Toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 490, doi. 10.1038/clpt.2009.149
- By:
- Publication type:
- Article
How a US Regulator Can Encourage New Science.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 471, doi. 10.1038/clpt.2009.188
- By:
- Publication type:
- Article
Clinical Physiology and Pharmacology: The Essentials.
- Published in:
- 2009
- By:
- Publication type:
- Book Review
When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 475, doi. 10.1038/clpt.2009.190
- By:
- Publication type:
- Article
Nephropharmacology: Drugs and the Kidney.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 453, doi. 10.1038/clpt.2009.191
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 460, doi. 10.1038/clpt.2009.196
- Publication type:
- Article
In This Issue.
- Published in:
- 2009
- Publication type:
- Abstract
Highlights.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Comparison of Manual and Automated Measurements of the QT Interval in Healthy Volunteers: An Analysis of Five Thorough QT Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 5, p. 503, doi. 10.1038/clpt.2009.34
- By:
- Publication type:
- Article